Nearly six out of ten Coloradans say that they support keeping retail marijuana production and sales legal, according to statewide polling data released by Quinnipiac University.
The figure is a five percent increase in support since voters approved the law in November 2012. A September 2014 statewide NBC News/Marist College poll previously reported that 55 percent of Coloradoans favored the law.
Men and younger voters were most likely to support legalization. Voters ages 18 to 34 overwhelmingly favored state law (86 percent to 16 percent) while 50 percent of those ages 55 and older opposed it.
Male voters supported the legalization by a margin of 63 percent to 33 percent, while women only favored the law by a margin of 53 percent to 44 percent.
The gender and age differences in support are not surprising. A just-published study in the February issue of the journal Drug Abuse and Alcohol Dependence reports that women are twice as likely as men to perceive significant risks associated with the use of cannabis. The study reported that those least likely to perceive significant harms associated with cannabis are those between the ages of 18 to 25, those who have completed high-school and/or college, and those with annual household incomes exceeding $75,000.
According to newly released figures by the Colorado Department of Revenue, retail sales of marijuana totaled just under $700 million in Colorado in 2014 – the first full year during which sales of marijuana for both medical and recreational purposes were allowed.
NORML reviews the top news stories of 2014.
#1 Marijuana Legalization Measures Win Big On Election Day
Voters in Oregon and Alaska decided on Election Day in favor of statewide initiatives legalizing the commercial production and sale of marijuana for adults, while voters in the nation’s capitol and in numerous other cities nationwide similarly decided on local measures to eliminate marijuana possession penalties.
#2 Colorado And Washington Begin Regulating Retail Marijuana Sales
Two states, Colorado and Washington, initiated retail marijuana sales in 2014. Colorado’s program began on January 1. In Washington, state-licensed retail outlets began legally selling cannabis to adults in July.
#3 Congress Enacts Measure Protecting State-Sponsored Medi-Pot Programs
President Barack Obama signed spending legislation into law in December that included a provision limiting the Justice Department’s ability to take criminal action against state-licensed individuals or operations that are acting in full compliance with the medical marijuana laws of their states. The amendment states, “None of the funds made available in this act to the Department of Justice may be used … to prevent … states … from implementing their own state laws that authorize the use, distribution, possession, or cultivation of medical marijuana.”
#4 Congress Moves To Permit State-Sanctioned Hemp Cultivation
Federal lawmakers approved legislation in February permitting state-sponsored hemp cultivation to move forward despite the plant’s federal status as a Schedule I prohibited substance.
#5 Federal Judge Hears Challenge To Cannabis’ Schedule I Status
United States District Judge Kimberly Mueller heard five days of testimony in October in regard to the constitutionality of marijuana’s Schedule I status under federal law. Defense counsel and their experts argued that the scientific literature is not supportive of the plant’s present categorization. Judge Mueller is expected to make her ruling in early 2015.
#6 JAMA: Fewer Opiate-Related Deaths In Medical Marijuana States
The enactment of statewide medicinal marijuana laws is associated with significantly lower state-level opioid overdose mortality rates, according to data published in August in JAMA Internal Medicine. Researchers reported, “States with medical cannabis laws had a 24.8 percent lower mean annual opioid overdose mortality rate compared with states without medical cannabis laws.”
#7 President Acknowledges That Booze Is More Harmful Than Marijuana
Consuming cannabis is less harmful to the individual than is drinking alcohol, President Barack Obama acknowledged in January in an interview with The New Yorker. “I don’t think it (marijuana) is more dangerous than alcohol,” he stated. He added, [W]e should not be locking up kids or individual users for long stretches of jail time.”
#8 Study: Medical Marijuana States Have Fewer Violent Crimes
Medicinal cannabis laws are not associated with any rise in statewide criminal activity, according to data published in April in the journal PLoS ONE. “Medical marijuana laws were not found to have a crime exacerbating effect on any of the seven crime types. On the contrary, our findings indicated that MML precedes a reduction in homicide and assault,” authors concluded. “In sum, these findings run counter to arguments suggesting the legalization of marijuana for medical purposes poses a danger to public health in terms of exposure to violent crime and property crimes.”
#9 NYT Editors Opine In Favor Of Legalizing Cannabis
The New York Times editorial board in July called upon federal lawmakers to end the criminalization of cannabis for those over the age of 21. The paper’s editors opined: “The federal government should repeal the ban on marijuana. … Moderate use of marijuana does not appear to pose a risk for otherwise healthy adults. … [W]e believe that on every level, … the balance falls squarely on the side of national legalization.”
#10 Americans Say Marijuana Is Less Harmful To Health Than Sugar
Americans believe that consuming cannabis poses less harm to health than does the consumption of tobacco, alcohol, or sugar, according to the findings of a Wall Street Journal/NBC News poll released in March. Respondents were asked which of the four substances they believed to be “most harmful to a person’s overall health.” Most respondents said tobacco (49 percent), followed by alcohol (24 percent) and sugar (15 percent).
State Public Health Department officials have recommended over $7 million dollars in grant funding to pay for a series of state-sponsored clinical trials to assess the safety and efficacy of cannabis and cannabinoids.
The proposed studies include a pair of clinical trials to evaluate the use of cannabidiol (CBD), a nonpsychotropic plant cannabinoid, for patients with pediatric epilepsy. Two additional trials will assess the use of cannabis for patients suffering from post-traumatic stress. Other studies will assess the efficacy of either cannabis or CBD in the treatment of Parkinson’s disease, brain tumors, ulcerative colitis, and pain management. (More specific summaries of all eight proposed studies are available online here.)
Grant funding for the proposed studies requires final approval by the state Board of Health in December.
Following funding approval, researchers will still be required to gain additional federal approval in order to obtain access to research-grade cannabis or CBD.
The state of California previously sponsored a similar series of clinical trials assessing the safety and efficacy of marijuana. Those studies evaluated the use of whole-plant cannabis in patients with neuropathy, multiple sclerosis, and autoimmune deficiencies. A summary of those trials, published in 2012, concluded, “Based on evidence currently available the Schedule I classification is not tenable; it is not accurate that cannabis has no medical value, or that information on safety is lacking.”
The political and cultural victories for the marijuana legalization movement continue to accumulate as new developments lead us closer to the ultimate goal of full legalization. Just in the last couple of weeks, we’ve seen the powerful, unambiguous endorsement of full legalization by the most influential newspaper in America: The New York Times.
That endorsement was followed by a series of six follow-up editorials explaining in more detail precisely why the Times decided to join the fight to end prohibition. Additionally, The Brookings Institution, a highly respected Washington, DC think tank, published a very favorable report card on the first six months of the legal sales of marijuana in Colorado.
These were both significant events, because they involved respected institutions known for their careful and thorough analysis of important public policy issues. Neither has a history of backing a pro-pot agenda, so their support both elevates the issue and makes a strong argument for regulation.
More than six out of ten Americans – including majorities of self-identified Democrats, Independents, and Republicans – support the regulation and retail sale of marijuana in Colorado, according to the findings of a nationwide HuffPost.com/YouGov poll released today.
Colorado voters in 2012 approved a statewide initiative legalizing the personal consumption and cultivation of the plant. The measure also allows for the state-licensed commercial production and retail sales of cannabis to those over the age of 21. Commercial cannabis sales began on January 1st of this year. To date, these sales have generated nearly $11 million in tax revenue.
Sixty-one percent of Americans – including 68 percent of Democrats, 60 percent of Independents, and 52 percent of Republicans – say they “support” Colorado’s efforts to regulate the commercial cannabis market. Only 27 percent of respondents oppose the Colorado law.
Respondents between the ages of 18 and 29 (65 percent) as well as those age 65 and older (64 percent) were most likely to support Colorado’s efforts, while those between the ages of 45 to 65 (55 percent) were less likely to do so.
The results of a separate poll of Colorado voters commissioned by Quinnipiac University in April similarly reported that most Coloradoans support the state’s efforts to regulate marijuana sales and consumption.
Similarly licensed commercial retail sales of cannabis began last week in Washington state.
In response to a separate HuffPost/YouGov poll question, 54 percent of those surveyed said that the US government should not enforce federal anti-marijuana laws in states that have legalized and regulated the plant. Only 29 percent of respondents endorsed the notion of enforcing federal prohibition in states that are pursuing alternative regulatory schemes.
“Every day in America, hundreds of thousands of people engage in transactions involving the recreational use of marijuana, but only in two states – Colorado and Washington – do these transactions take place in a safe, above-ground, state-licensed facility where consumers must show proof of age, the product sold is of known quality, and the sales are taxed in a manner to help fund necessary state and local services,” NORML Deputy Director Paul Armentano said. “Not surprisingly, most Americans prefer to have cannabis regulated in this sort of legal setting as opposed to an environment where the plant’s production and sale is entirely unregulated and those who consume it are stigmatized and classified as criminals.”
Complete poll results are available online here.